Citation Impact
Citing Papers
Descriptive analysis of estrogen receptor (ER)‐negative, progesterone receptor (PR)‐negative, and HER2‐negative invasive breast cancer, the so‐called triple‐negative phenotype
2007 Standout
KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)
2009 Standout
Presence of papillomavirus sequences in condylomatous lesions of the mamillae and in invasive carcinoma of the breast
2004 StandoutNobel
Somatic mutations in the p53 gene and prognosis in breast cancer: a meta-analysis
1999
Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
2009 Standout
PROGNOSTIC SIGNIFICANCE OF THE CO-EXPRESSION OF p53 AND c-erbB-2 PROTEINS IN BREAST CANCER
1996
Systematic review of the health benefits of physical activity and fitness in school-aged children and youth
2010 Standout
Correlation between p53, c-erbB-2, and topoisomerase II? expression, DNA ploidy, hormonal receptor status and proliferation in 356 node-negative breast carcinomas: prognostic implications
1999
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
2007 Standout
Head and neck squamous cell carcinoma
2020 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Engineering precision nanoparticles for drug delivery
2020 Standout
Effects of bone metastases on bone metabolism: implications for diagnosis, imaging and assessment of response to cancer treatment
1996
Structural changes in aging bone: Osteopenia in the proximal femurs of female mice
1991
Relationship betweenp53 gene abnormalities and other tumour characteristics in breast-cancer prognosis
1996
Role of Transforming Growth Factor β in Human Disease
2000 Standout
Almost all articles on cancer prognostic markers report statistically significant results
2007
Variation of ER status between primary and metastatic breast cancer and relationship to p53 expression ☆ ☆This study was supported by the National Natural Science Foundation of China (No. 39870753) and Changhai Hospital ‘123’ Project.
2001
Diagnosis and Treatment of Low Back Pain: A Joint Clinical Practice Guideline from the American College of Physicians and the American Pain Society
2007 Standout
An overview of chemical additives present in plastics: Migration, release, fate and environmental impact during their use, disposal and recycling
2017 Standout
Premature ageing in mice expressing defective mitochondrial DNA polymerase
2004 StandoutNature
Diagnosis of osteoporosis and assessment of fracture risk
2002 Standout
Skeletal Effects of Estrogen*
1994
Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points.
1996 Standout
Part II: Cancer in Indigenous Africans—causes and control
2008
Cushing's syndrome
2015 Standout
Cancer Statistics, 2006
2006 Standout
The burden of non-communicable diseases in South Africa
2009 Standout
Molecular determinants of resistance to antiandrogen therapy
2003 Standout
Flutamide withdrawal syndrome: its impact on clinical trials in hormone-refractory prostate cancer.
1993
Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer
2003 Standout
The prognostic value of p53 and c-erb b-2 immunostaining is overrated for patients with lymph node negative breast carcinoma
2000
Tamoxifen elevates transforming growth factor–β and suppresses diet–induced formation of lipid lesions in mouse aorta
1995
Do Pressures to Publish Increase Scientists' Bias? An Empirical Support from US States Data
2010 Standout
Effects of Raloxifene on Bone Mineral Density, Serum Cholesterol Concentrations, and Uterine Endometrium in Postmenopausal Women
1997 Standout
Global cancer statistics
2011 Standout
Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms
2004 Standout
Quantum imaging with undetected photons
2014 StandoutNatureNobel
Optimisation of breast cancer management in low-resource and middle-resource countries: executive summary of the Breast Health Global Initiative consensus, 2010
2011
Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
1998 Standout
Combined modality radioimmunotherapy
2002
Effects of Tamoxifen on Bone Mineral Density in Postmenopausal Women with Breast Cancer
1992
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
African‐American/White differences in breast carcinoma
2004
Papillomavirus E5: the smallest oncoprotein with many functions
2011
MORTYN JONES MEMORIAL LECTURE
1993
The descriptive epidemiology of female breast cancer: An international comparison of screening, incidence, survival and mortality
2012
A survey of telomerase activity in human cancer
1997 Standout
Resistance training and bone mineral density in adolescent females
2001
Sex Steroids and Bone
2002
Halogenated Flame Retardants: Do the Fire Safety Benefits Justify the Risks?
2010
Metastasis to bone: causes, consequences and therapeutic opportunities
2002 Standout
Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic renal failure
1999
Breast Cancer in Limited-Resource Countries: Health Care Systems and Public Policy
2006
Effect of tamoxifen on bone mineral density measured by dual-energy x-ray absorptiometry in healthy premenopausal and postmenopausal women.
1996
The Ki-67 protein: From the known and the unknown
2000 Standout
Selected food intake and risk of endometriosis
2004 Standout
Oncogenic Viruses and Breast Cancer: Mouse Mammary Tumor Virus (MMTV), Bovine Leukemia Virus (BLV), Human Papilloma Virus (HPV), and Epstein–Barr Virus (EBV)
2018
Use of bone turnover marker, pyridinoline cross-linked carboxyterminal telopeptide of type I collagen (ICTP), in the assessment and monitoring of bone metastasis in prostate cancer
1999
Atherosclerosis
2001 Standout
Guideline implementation for breast healthcare in low-income and middle-income countries
2008
Thermally insulating and fire-retardant lightweight anisotropic foams based on nanocellulose and graphene oxide
2014 Standout
Interaction of Estrogenic Chemicals and Phytoestrogens with Estrogen Receptor β
1998 Standout
Neurodevelopmental Outcomes of Very Low-Birth-Weight Infants With Necrotizing Enterocolitis
2007
Nutrition and endometrial cancer
1996
Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults
2003 Standout
Disparities in breast cancer outcomes between Caucasian and African American women: a model for describing the relationship of biological and nonbiological factors
2013
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
2001 Standout
Epidemiology of osteoporosis
1992
Vertebral fracture assessment using a semiquantitative technique
1993 Standout
Tamoxifen Decreases Cholesterol Sevenfold and Abolishes Lipid Lesion Development in Apolipoprotein E Knockout Mice
1997
Estrogen Receptor Null Mice: What Have We Learned and Where Will They Lead Us?
1999 Standout
Ovarian cancer statistics, 2018
2018 Standout
Prostate intraepithelial neoplasia induced by prostate restricted Akt activation: The MPAKT model
2003
Mechanisms of Estrogen Action
2001 Standout
Potential and Challenges for Mid-Infrared Sensors in Breath Diagnostics
2009
Relation of prediagnostic serum estrogen and androgen levels to breast cancer risk.
1996
Analysis of telomerase activity levels in breast cancer: positive detection at the in situ breast carcinoma stage.
1997
Molecular Firefighting—How Modern Phosphorus Chemistry Can Help Solve the Challenge of Flame Retardancy
2018 Standout
Cancer treatment and survivorship statistics, 2016
2016 Standout
From Estrogen-Centric to Aging and Oxidative Stress: A Revised Perspective of the Pathogenesis of Osteoporosis
2010 Standout
Endogenous Sex Hormones and Breast Cancer in Postmenopausal Women: Reanalysis of Nine Prospective Studies
2002 Standout
The Oxytocin Receptor System: Structure, Function, and Regulation
2001 Standout
Skeletal complications of malignancy
1997 Standout
Genetic aspects of adrenocortical tumours and hyperplasias
2012
Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: Recommendation Statement.
2015
Global cancer statistics, 2012
2015 Standout
The diagnosis of osteoporosis
1994 Standout
Selective Estrogen Receptor Modulators: Clinical Spectrum*
1999
Apparent Pre- and Postmenopausal Bone Loss Evaluated by DXA at Different Skeletal Sites in Women: The OFELY Cohort
1997
Fatal myocardial infarction in the Scottish adjuvant tamoxifen trial. The Scottish Breast Cancer Committee.
1991
Prognostic significance of tumor cell proliferation rate as determined by the MIB-1 antibody in breast carcinoma: its relationship with vimentin and p53 protein.
1996
Early onset of neoplasia in the prostate and skin of mice with tissue-specific deletion of Pten
2004 StandoutNobel
Cancer treatment and survivorship statistics, 2014
2014 Standout
Works of Maira Caleffi being referenced
Premenopausal bone loss in the lumbar spine and neck of femur: A study of 225 Caucasian women
1990
Bone mineral content of women receiving tamoxifen for mastalgia
1989
Steroid hormones in lymph and blood from women with early breast cancer
1991
Osteocalcin: a potential marker of metastatic bone disease and response to treatment
1988
Development and validation of a simple questionnaire for the identification of hereditary breast cancer in primary care
2009
Polybrominated diphenyl ethers and polychlorinated biphenyls in human breast adipose samples from Brazil
2008
Evidence for an Association of Human Papillomavirus and Breast Carcinomas
2004
Tamoxifen protects against steroid-induced bone loss
1992
Breast Cancer in Limited-Resource Countries: Early Detection and Access to Care
2006
Detection of R337H, a germline TP53 mutation predisposing to multiple cancers, in asymptomatic women participating in a breast cancer screening program in Southern Brazil
2008
Effect of tamoxifen on oestrogen binding, lipid and lipoprotein concentrations and blood clotting parameters in premenopausal women with breast pain
1988
Breast cancer management in middle-resource countries (MRCs): Consensus statement from the Breast Health Global Initiative
2011
P53 gene mutations and steroid receptor status in breast cancer. Clinicopathologic correlations and prognostic assessment
1994
The role of breast cancer civil society in different resource settings
2011
The binding of blood‐borne estrogens in normal vegetarian and omnivorous women and the risk of breast cancer
1988
A phase II study of doxorubicin/paclitaxel plus G-CSF for metastatic breast cancer.
1997
A comparison of the fatty acid profiles of subcutaneous fat from women with breast cancer, benign breast disease and normal controls.
1988